Chemotherapy delivered directly to abdomen shows promise in early trial
NCT ID NCT01061515
First seen Jun 26, 2026 · Last updated Jun 26, 2026
Summary
This early-phase trial tests a combination of three drugs for people whose appendix or colon cancer has spread to the lining of the abdomen (peritoneal carcinomatosis). After surgery to remove visible tumors, patients receive chemotherapy directly into the abdomen (oxaliplatin) plus oral and intravenous drugs (capecitabine and bevacizumab). The main goal is to find the safest dose and check for side effects in 21 participants.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
oxaliplatin (chemotherapy), capecitabine (chemotherapy), bevacizumab (targeted therapy)
What this could lead to
If this works, it could point toward a more effective way to deliver chemotherapy directly to the abdomen for people with advanced abdominal cancers, potentially improving survival.
What could go wrong
This is a very early (Phase 1) trial with only 21 participants, so it is primarily testing safety and dosing, not effectiveness. The combination may cause significant side effects, and results may not apply to all patients.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CARCINOMA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Washington University School of Medicine
St Louis, Missouri, 63110, United States